Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.
Thrive Capital led the round, with participation from GV (Google Ventures) and existing investor Alphabet.
WHAT IT DOES
Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs...
